Drugs and biologicals
Ended Purchase Order Awarded Last action
- Contract number
- 75N91020P00186
- Awardee
-
Wilson Wolf Manufacturing, LLC UEI L1HKPVNJ33J8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,649
Award facts
- Contract value 100% obligated
- $24,649.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$12 | |
| Original award | $24,661 |
About this award
This is a $24,649.07 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract is for the procurement of drugs and biologicals, with a period of performance ending on January 3, 2025.
The prime contractor is Wilson Wolf Manufacturing, LLC, doing business as Wilson Wolf, a self-certified small disadvantaged business and limited liability company. Wilson Wolf is a manufacturer of specialized biological and medical supplies, including the G-REX series of gas permeable cell culture devices, which are critical for the manufacture of cellular therapy products used in the treatment of cancer, hematological malignancies, and other diseases. This contract supports the NCI Surgery Branch's adoptive cell transfer therapy program for cancer patients.
The contract was awarded without a set-aside designation, but Wilson Wolf's status as a small disadvantaged business likely contributed to its selection as the prime contractor. The company has a history of providing a range of products to support clinical research and cellular therapy programs at the NIH, including the NCI and NIH Clinical Center.
Quick answers
Who was awarded contract 75N91020P00186?
75N91020P00186 was awarded to Wilson Wolf Manufacturing, LLC by National Cancer Institute (National Institutes of Health) on February 4, 2020.
How much is contract 75N91020P00186 worth?
The government has obligated $24,649 on 75N91020P00186.
Was contract 75N91020P00186 competed?
The extent of competition for 75N91020P00186 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award